海外の治験の状況「前立腺癌」での検索結果
118件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Study of Immunotherapy to Treat Advanced Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Peru, Poland, Puerto Rico, Romania, Russian Federation, Spain, United Kingdom, United States
- 2009-03-12
Not recruiting
- Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- Brazil
- 2014-08-29
Not recruiting
- Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer
- Secondary Malignant Neoplasm of Lymph Node;Prostatic Neoplasms;Secondary Malignant Neoplasm of Lymph Node;Prostatic Neoplasms
- Colombia
- 2014-05-13
Not recruiting
- A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Colombia
- 2016-09-14
Not recruiting
- A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
- Prostatic Neoplasms
- Argentina, Belgium, Brazil, Canada, France, Singapore, Spain, United States
- 2012-07-06
Not recruiting
- Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-12-03
Not Recruiting
- Tasquinimod for metastatic castrate-resistant prostate cancer
- Metastatic Castrate-Resistant Prostate Cancer br>MedDRA version: 17.1 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Estonia, France, Germany, Greece, Guatemala, Iceland, India, Israel, Italy, Korea, Republic of, Latvia, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Peru, Romania, Slovakia, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2010-10-28
Not recruiting
- Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
- Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male;Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male;Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male;Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male
- Australia, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Greece, Hong Kong, Hungary, India, Indonesia, Korea, Republic of, Malaysia, Mexico, New Zealand, Poland, Puerto Rico, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, United States
- 2010-10-07
Not recruiting
- Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, India, Italy, Mexico, Netherlands, Norway, Peru, Poland, Puerto Rico, Romania, Russian Federation, Spain, Sweden, Turkey, United Kingdom, United States
- 2010-01-26
Not Recruiting
- Abiraterone acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
- Malignant neoplasm of prostate. Prostatic Neoplasms Castration-Resistant C61 C04.588.945.440.770.500;C00-D48;C04.588.945.440.770.500
- Argentina, Brazil, Colombia
- 2016-04-11